Jonan Boto
Advertisement
Jonan Boto is a Director for Kin + Carta Advise.
Articles by Jonan Boto
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
3
BioPhorum Unites 20 Organizations to Modernize Small Molecule Production
4
Lonza Increases HPAPI Production at Visp Facility
5